Accretion Pharmaceuticals Limited (NSE:ACCPL)

Accretion Pharmaceuticals Statistics

Total Valuation

NSE:ACCPL has a market cap or net worth of INR 711.98 million. The enterprise value is 788.98 million.

Market Cap	711.98M
Enterprise Value	788.98M

Important Dates

The last earnings date was Friday, January 9, 2026.

Earnings Date	Jan 9, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:ACCPL has 11.12 million shares outstanding. The number of shares has increased by 17.78% in one year.

Current Share Class	11.12M
Shares Outstanding	11.12M
Shares Change (YoY)	+17.78%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	73.50%
Owned by Institutions (%)	n/a
Float	2.95M

Valuation Ratios

The trailing PE ratio is 6.52.

PE Ratio	6.52
Forward PE	n/a
PS Ratio	0.86
PB Ratio	1.53
P/TBV Ratio	1.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	8.69
EV / Sales	0.95
EV / EBITDA	5.27
EV / EBIT	5.67
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.35, with a Debt / Equity ratio of 0.17.

Current Ratio	4.35
Quick Ratio	1.91
Debt / Equity	0.17
Debt / EBITDA	0.52
Debt / FCF	n/a
Interest Coverage	13.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	18.08%
Return on Capital Employed (ROCE)	29.27%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	6.61M
Profits Per Employee	726,480
Employee Count	125
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:ACCPL has paid 38.00 million in taxes.

Income Tax	38.00M
Effective Tax Rate	29.50%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	82.70
200-Day Moving Average	n/a
Relative Strength Index (RSI)	30.22
Average Volume (20 Days)	18,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ACCPL had revenue of INR 826.43 million and earned 90.81 million in profits. Earnings per share was 9.82.

Revenue	826.43M
Gross Profit	224.49M
Operating Income	139.23M
Pretax Income	128.81M
Net Income	90.81M
EBITDA	149.85M
EBIT	139.23M
Earnings Per Share (EPS)	9.82

Balance Sheet

The company has 1.56 million in cash and 78.56 million in debt, with a net cash position of -77.00 million or -6.93 per share.

Cash & Cash Equivalents	1.56M
Total Debt	78.56M
Net Cash	-77.00M
Net Cash Per Share	-6.93
Equity (Book Value)	465.79M
Book Value Per Share	45.18
Working Capital	385.35M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 27.16%, with operating and profit margins of 16.85% and 10.99%.

Gross Margin	27.16%
Operating Margin	16.85%
Pretax Margin	15.59%
Profit Margin	10.99%
EBITDA Margin	18.13%
EBIT Margin	16.85%
FCF Margin	n/a

Dividends & Yields

NSE:ACCPL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.78%
Shareholder Yield	-17.78%
Earnings Yield	12.75%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NSE:ACCPL has an Altman Z-Score of 7.3 and a Piotroski F-Score of 1.

Altman Z-Score	7.3
Piotroski F-Score	1